Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Medpace Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides cardiovascular, hematology, oncology, neurology, pediatrics, nephrology, and diagnostic services. Medpace Holdings serves patients worldwide.
Website: medpace.com



Growth: Good revenue growth rate 17.7%, there is slowdown compared to average historical growth rates 27.4%. The revenue growth dynamics is stable Site traffic for the last 3 months showed a change of -17.4%

Profitability: LTM EBITDA margin is positive, +19.5%. On average the margin is improving unsteadily. Gross margin is normal, +30.4%. In the last quarter the company beat the estimated EPS, +26.1%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.39 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 4.0% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 199.4% higher than minimum and 5.7% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.7x by EV / Sales multiple , the company can be 38.1% overvalued

Insiders: For the last 3 months insiders sold company shares on $355.6 mln (-2.870% of cap.)

Key Financials (Download financials)

Ticker: MEDP
Share price, USD:  (-2.0%)389.77
year average price 285.39  


year start price 200.14 2023-04-28

min close price 200.14 2023-04-28

max close price 413.31 2024-03-21

current price 389.77 2024-04-26
Common stocks: 30 843 000

Dividend Yield:  0.0%
FCF Yield LTM: 4.0%
EV / LTM EBITDA: 30.8x
EV / EBITDA annualized: 26.5x
Last revenue growth (y/y):  17.7%
Last growth of EBITDA (y/y):  20.7%
Historical revenue growth:  27.4%
Historical growth of EBITDA:  21.0%
EV / Sales: 6.0x
Margin (EBITDA LTM / Revenue): 19.5%
Fundamental value created in LTM:
Market Cap ($m): 12 022
Net Debt ($m): -271
EV (Enterprise Value): 11 751
Price to Book: 17.9x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-04-25Zacks Investment Research

Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"

2024-04-22Zacks Investment Research

Medpace (MEDP) Beats Q1 Earnings Estimates

2024-04-15Zacks Investment Research

Medpace (MEDP) Earnings Expected to Grow: Should You Buy?

2024-04-05Zacks Investment Research

Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report?

2024-03-28Zacks Investment Research

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

2024-03-04Zacks Investment Research

Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why

2024-03-04Zacks Investment Research

Medpace (MEDP) Is Up 0.64% in One Week: What You Should Know

2024-02-15Zacks Investment Research

3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)

2024-02-15Zacks Investment Research

Are You Looking for a Top Momentum Pick? Why Medpace (MEDP) is a Great Choice

2024-02-13Seeking Alpha

Medpace Holdings, Inc. (MEDP) Q4 2023 Earnings Call Transcript
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol MEDP MEDP MEDP MEDP MEDP MEDP MEDP
reportedCurrency USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M
fillingDate 2024-04-23 2024-02-12 2023-10-24 2023-07-25 2023-04-25 2022-12-31 2022-10-25
acceptedDate 2024-04-23 16:02:32 2024-02-12 16:15:53 2023-10-24 16:02:38 2023-07-25 16:02:37 2023-04-25 16:03:36 2022-12-31 00:00:00 2022-10-25 16:13:02
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4 Q3
revenue 511M 498M 492M 461M 434M 394M 384M
costOfRevenue 356M 362M 359M 337M 304M 278M 265M
grossProfit 155M 137M 133M 124M 130M 116M 119M
grossProfitRatio 0.304 0.274 0.270 0.270 0.300 0.294 0.310
researchAndDevelopmentExpenses 0 0 0 0 0 0 0
generalAndAdministrativeExpenses 0 41M 0 0 0 0 0
sellingAndMarketingExpenses 0 2M 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 44M 43M 41M 39M 38M 33M 35M
otherExpenses 5M 3M -2M 7M 6M 6M 6M
operatingExpenses 51M 49M 48M 46M 44M 39M 41M
costAndExpenses 407M 411M 408M 382M 348M 318M 306M
interestIncome 0 2M 105 000 0 0 0 0
interestExpense 4M 2M 105 000 1M 861 000 827 000 2M
depreciationAndAmortization 7M 7M 7M 5M 6M 6M 11M
ebitda 111M 96M 90M 84M 92M 82M 89M
ebitdaratio 0.217 0.194 0.183 0.181 0.212 0.209 0.233
operatingIncome 104M 87M 85M 78M 86M 76M 78M
operatingIncomeRatio 0.204 0.175 0.172 0.170 0.199 0.194 0.203
totalOtherIncomeExpensesNet 5M 2M -2M -3M -174 000 -3M 4M
incomeBeforeTax 113M 91M 83M 76M 86M 74M 82M
incomeBeforeTaxRatio 0.221 0.182 0.169 0.164 0.198 0.187 0.213
incomeTaxExpense 10M 12M 13M 15M 13M 5M 16M
netIncome 103M 78M 71M 61M 73M 69M 66M
netIncomeRatio 0.201 0.157 0.143 0.133 0.168 0.174 0.172
eps 3.320 2.550 2.300 2.000 2.350 2.200 2.130
epsdiluted 3.200 2.460 2.220 1.930 2.270 2.120 2.050
weightedAverageShsOut 31M 31M 31M 31M 31M 31M 31M
weightedAverageShsOutDil 32M 32M 32M 32M 32M 32M 32M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol MEDP MEDP MEDP MEDP MEDP MEDP MEDP
reportedCurrency USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M
fillingDate 2024-04-23 2024-02-12 2023-10-24 2023-07-25 2023-04-25 2022-12-31 2022-10-25
acceptedDate 2024-04-23 16:02:32 2024-02-12 16:15:53 2023-10-24 16:02:38 2023-07-25 16:02:37 2023-04-25 16:03:36 2022-12-31 00:00:00 2022-10-25 16:13:02
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 407M 245M 95M 39M 47M 28M 31M
shortTermInvestments 0 0 0 0 0 0 0
cashAndShortTermInvestments 407M 245M 95M 39M 47M 28M 31M
netReceivables 279M 298M 293M 275M 258M 253M 249M
inventory 0 1.000 1.000 0 0 0 0
otherCurrentAssets 59M 50M 61M 65M 63M 52M 58M
totalCurrentAssets 745M 594M 449M 379M 368M 334M 338M
propertyPlantEquipmentNet 257M 265M 259M 255M 257M 249M 244M
goodwill 662M 662M 662M 662M 662M 662M 662M
intangibleAssets 35M 36M 36M 37M 37M 38M 39M
goodwillAndIntangibleAssets 698M 698M 699M 699M 700M 700M 701M
longTermInvestments 0 0 0 0 0 0 0
taxAssets 75M 74M 59M 52M 49M 48M 27M
otherNonCurrentAssets 20M 25M 21M 22M 22M 21M 19M
totalNonCurrentAssets 1 051M 1 063M 1 038M 1 028M 1 028M 1 019M 991M
otherAssets 0 0 0 0 0 0 0
totalAssets 1 796M 1 657M 1 487M 1 407M 1 396M 1 352M 1 328M
accountPayables 24M 32M 29M 34M 37M 33M 28M
shortTermDebt 272M 293M 265M 55M 115M 50M 140M
taxPayables 0 0 0 0 0 0 0
deferredRevenue 617M 560M 519M 491M 466M 463M 418M
otherCurrentLiabilities 43M 40M 36M 273M 264M 258M 235M
totalCurrentLiabilities 957M 925M 849M 852M 882M 803M 821M
longTermDebt 136M 142M 143M 139M 143M 139M 139M
deferredRevenueNonCurrent 0 0 0 0 0 1M 0
deferredTaxLiabilitiesNonCurrent 2M 2M 1M 1M 1M 1M 911 000
otherNonCurrentLiabilities 29M 28M 23M 23M 23M 22M -428M
totalNonCurrentLiabilities 168M 173M 167M 163M 167M 163M 158M
otherLiabilities 0 0 0 0 0 0 0
capitalLeaseObligations 136M 142M 143M 139M 143M 139M 139M
totalLiabilities 1 124M 1 098M 1 016M 1 016M 1 048M 966M 979M
preferredStock 0 0 0 0 0 0 0
commonStock 310 000 308 000 307 000 306 000 306 000 309 000 309 000
retainedEarnings -119M -222M -300M -371M -408M -360M -380M
accumulatedOtherComprehensiveIncomeLoss -12M -10M -13M -11M -11M -12M -16M
othertotalStockholdersEquity 802M 790M 784M 773M 766M 758M 746M
totalStockholdersEquity 672M 559M 471M 391M 347M 386M 350M
totalEquity 672M 559M 471M 391M 347M 386M 350M
totalLiabilitiesAndStockholdersEquity 1 796M 1 657M 1 487M 1 407M 1 396M 1 352M 1 328M
minorityInterest 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 1 796M 1 657M 1 487M 1 407M 1 396M 1 352M 1 328M
totalInvestments 0 0 0 0 0 0 0
totalDebt 136M 142M 143M 194M 258M 189M 279M
netDebt -271M -103M 48M 155M 211M 161M 248M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol MEDP MEDP MEDP MEDP MEDP MEDP MEDP
reportedCurrency USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M
fillingDate 2024-04-23 2024-02-12 2023-10-24 2023-07-25 2023-04-25 2022-12-31 2022-10-25
acceptedDate 2024-04-23 16:02:32 2024-02-12 16:15:53 2023-10-24 16:02:38 2023-07-25 16:02:37 2023-04-25 16:03:36 2022-12-31 00:00:00 2022-10-25 16:13:02
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4 Q3
netIncome 103M 78M 71M 61M 73M 69M 66M
depreciationAndAmortization 7M 7M 7M 7M 6M 6M 6M
deferredIncomeTax -865 000 -14M -8M -3M -1M -21M -687 000
stockBasedCompensation 4M 5M 5M 5M 5M 6M 6M
changeInWorkingCapital 38M 73M 33M 7M -6M 75M 27M
accountsReceivables 19M -9M -18M 0 -4M -28M 0
inventory 0 9M 18M 0 0 0 0
accountsPayables -7M 2M -3M -2M 4M 6M -2M
otherWorkingCapital 63M 71M 36M 9M -7M 97M 29M
otherNonCashItems 1M 7M 7M 5M 3M 3M 5M
netCashProvidedByOperatingActivities 153M 156M 114M 83M 80M 137M 108M
investmentsInPropertyPlantAndEquipment -5M -10M -9M -8M -10M -9M -7M
acquisitionsNet 0 0 0 0 0 0 0
purchasesOfInvestments 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0
otherInvestingActivites 8M 2M 41 000 -21 000 10000.000 23 000 -8000.000
netCashUsedForInvestingActivites 3M -8M -9M -8M -10M -9M -7M
debtRepayment 0 0 -55M -75M -25M -115M -110M
commonStockIssued 0 2M 6M 0 0 0 0
commonStockRepurchased 0 0 0 -24M -120M -47M 0
dividendsPaid 0 0 0 0 0 0 0
otherFinancingActivites 8M 2M -49M 17M 92M 31M 892 000
netCashUsedProvidedByFinancingActivities 8M 2M -49M -82M -53M -131M -109M
effectOfForexChangesOnCash -1M 321 000 -382 000 375 000 767 000 915 000 -4M
netChangeInCash 162M 150M 56M -8M 19M -3M -12M
cashAtEndOfPeriod 407M 245M 95M 39M 47M 28M 31M
cashAtBeginningOfPeriod 245M 95M 39M 47M 28M 31M 43M
operatingCashFlow 153M 156M 114M 83M 80M 137M 108M
capitalExpenditure -5M -10M -9M -8M -10M -9M -7M
freeCashFlow 147M 146M 106M 74M 71M 127M 101M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Earning call transcript

2024 q1
2024-04-23 ET (fiscal 2024 q1)
2023 q4
2024-02-13 ET (fiscal 2023 q4)
2023 q3
2023-10-24 ET (fiscal 2023 q3)
2023 q2
2023-07-25 ET (fiscal 2023 q2)
2023 q1
2023-04-25 ET (fiscal 2023 q1)
2022 q4
2023-02-14 ET (fiscal 2022 q4)
2022 q3
2022-10-25 ET (fiscal 2022 q3)
2022 q2
2022-07-26 ET (fiscal 2022 q2)
2022 q1
2022-04-26 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-04-22 20:15 ET
Medpace Holdings, Inc. Reports First Quarter 2024 Results
2024-03-28 20:05 ET
Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024
2024-02-12 21:15 ET
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Results
2024-01-03 21:05 ET
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 12, 2024
2023-10-23 20:15 ET
Medpace Holdings, Inc. Reports Third Quarter 2023 Results
2023-09-26 20:05 ET
Medpace Holdings, Inc. to Report Third Quarter 2023 Financial Results on October 23, 2023
2023-07-24 20:15 ET
Medpace Holdings, Inc. Reports Second Quarter 2023 Results
2023-07-05 20:05 ET
Medpace Holdings, Inc. to Report Second Quarter 2023 Financial Results on July 24, 2023
2023-04-24 20:15 ET
Medpace Holdings, Inc. Reports First Quarter 2023 Results
2023-03-28 20:05 ET
Medpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023
2023-02-13 21:56 ET
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Results
2023-01-04 21:05 ET
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 13, 2023
2022-10-24 20:15 ET
Medpace Holdings, Inc. Reports Third Quarter 2022 Results
2022-09-27 20:05 ET
Medpace Holdings, Inc. to Report Third Quarter 2022 Financial Results on October 24, 2022
2022-07-25 20:15 ET
Medpace Holdings, Inc. Reports Second Quarter 2022 Results
2022-07-07 20:05 ET
Medpace Holdings, Inc. to Report Second Quarter 2022 Financial Results on July 25, 2022
2022-04-25 20:15 ET
Medpace Holdings, Inc. Reports First Quarter 2022 Results
2022-03-23 20:32 ET
Medpace Donation to Matthew 25: Ministries Funds Delivery of Relief Supplies to Ukraine
2022-03-17 20:05 ET
Medpace Holdings, Inc. to Report First Quarter 2022 Financial Results on April 25, 2022
2022-02-14 21:15 ET
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Results
2022-01-04 21:05 ET
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 14, 2022
2021-10-25 20:15 ET
Medpace Holdings, Inc. Reports Third Quarter 2021 Results
2021-09-07 20:05 ET
Medpace Holdings, Inc. to Report Third Quarter 2021 Financial Results on October 25, 2021
2021-08-30 20:05 ET
Medpace Holdings, Inc. to Present at Baird’s Global Healthcare Conference
2021-07-26 20:15 ET
Medpace Holdings, Inc. Announces Senior Leadership Changes
2021-07-26 20:15 ET
Medpace Holdings, Inc. Reports Second Quarter 2021 Results
2021-05-27 20:05 ET
Medpace Holdings, Inc. to Report Second Quarter 2021 Financial Results on July 26, 2021
2021-05-18 20:05 ET
Medpace Holdings, Inc. to Present at the Jefferies Virtual Healthcare Conference
2021-04-26 20:15 ET
Medpace Holdings, Inc. Reports First Quarter 2021 Results
2021-03-10 21:05 ET
Medpace Holdings, Inc. to Report First Quarter 2021 Financial Results on April 26, 2021
2021-02-15 21:15 ET
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2020 Results
2021-01-05 21:05 ET
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results on February 15, 2021
2020-10-29 20:05 ET
Medpace Holdings, Inc. to Present at the Credit Suisse Healthcare Conference
2020-10-26 20:15 ET
Medpace Holdings, Inc. Reports Third Quarter 2020 Results
2020-09-02 20:05 ET
Medpace Holdings, Inc. to Report Third Quarter 2020 Financial Results on October 26, 2020
2020-08-27 20:05 ET
Medpace Holdings, Inc. to Present at Baird's Global Healthcare Conference
2020-07-27 20:15 ET
Medpace Holdings, Inc. Reports Second Quarter 2020 Results
2020-05-26 20:05 ET
Medpace Holdings, Inc. to Present at Two Upcoming Investor Conferences
2020-05-18 20:05 ET
Medpace Holdings, Inc. to Report Second Quarter 2020 Financial Results on July 27, 2020
2020-04-28 20:15 ET
Medpace Holdings, Inc. Reports First Quarter 2020 Results
2020-04-03 20:05 ET
Medpace Holdings, Inc. to Report First Quarter 2020 Financial Results on April 28, 2020
2020-02-24 21:15 ET
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2019 Results
2020-01-14 21:05 ET
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2019 Financial Results on February 24, 2020
2019-10-31 20:00 ET
Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference
2019-10-28 20:15 ET
Medpace Holdings, Inc. Reports Third Quarter 2019 Results
2019-09-24 20:05 ET
Medpace Holdings, Inc. to Report Third Quarter 2019 Financial Results on October 28, 2019

SEC forms

Show financial reports only

SEC form 10
2024-04-23 16:02 ET
Medpace published news for 2024 q1
SEC form 10
2024-04-23 00:00 ET
Medpace published news for 2024 q1
SEC form 8
2024-04-22 16:15 ET
Medpace published news for 2024 q1
SEC form 8
2024-04-22 16:15 ET
Medpace reported for 2024 q1
SEC form 10
2024-02-13 00:00 ET
Medpace published news for 2023 q4
SEC form 8
2024-02-12 00:00 ET
Medpace reported for 2023 q4
SEC form 8
2024-02-12 00:00 ET
Medpace published news for 2023 q4
SEC form 10
2023-10-24 16:02 ET
Medpace published news for 2023 q3
SEC form 10
2023-10-24 00:00 ET
Medpace published news for 2023 q3
SEC form 8
2023-10-23 16:15 ET
Medpace reported for 2023 q3
SEC form 10
2023-07-25 00:00 ET
Medpace reported for 2023 q2
SEC form 6
2023-07-24 16:15 ET
Medpace reported for 2023 q2
SEC form 8
2023-07-24 00:00 ET
Medpace reported for 2023 q2
SEC form 10
2023-04-25 00:00 ET
Medpace published news for 2023 q1
SEC form 8
2023-04-24 00:00 ET
Medpace published news for 2023 q1
SEC form 6
2023-03-31 16:05 ET
Medpace published news for 2022 q4
SEC form 10
2023-02-14 16:07 ET
Medpace reported for 2022 q4
SEC form 10
2023-02-14 00:00 ET
Medpace reported for 2022 q4
SEC form 6
2023-02-13 16:55 ET
Medpace published news for 2022 q4
SEC form 8
2023-02-13 00:00 ET
Medpace reported for 2022 q4
SEC form 6
2023-01-18 17:00 ET
Medpace published news for 2022 q4
SEC form 6
2023-01-18 16:30 ET
Medpace published news for 2022 q4
SEC form 6
2023-01-03 16:27 ET
Medpace published news for 2022 q4
SEC form 10
2022-10-25 16:13 ET
Medpace reported for 2022 q3
SEC form 10
2022-10-25 00:00 ET
Medpace reported for 2022 q3
SEC form 6
2022-10-24 16:16 ET
Medpace published news for 2022 q3
SEC form 8
2022-10-24 00:00 ET
Medpace reported for 2022 q3
SEC form 10
2022-07-26 16:06 ET
Medpace reported for 2022 q2
SEC form 10
2022-07-26 00:00 ET
Medpace reported for 2022 q2
SEC form 6
2022-07-25 16:16 ET
Medpace published news for 2022 q2
SEC form 8
2022-07-25 00:00 ET
Medpace reported for 2022 q2
SEC form 6
2022-06-10 16:16 ET
Medpace published news for 2022 q1
SEC form 6
2022-05-26 16:31 ET
Medpace published news for 2022 q1
SEC form 6
2022-05-20 17:01 ET
Medpace published news for 2022 q1
SEC form 10
2022-04-26 16:06 ET
Medpace reported for 2022 q1
SEC form 10
2022-04-26 00:00 ET
Medpace reported for 2022 q1
SEC form 6
2022-04-25 16:17 ET
Medpace published news for 2022 q1
SEC form 8
2022-04-25 00:00 ET
Medpace reported for 2022 q1
SEC form 6
2022-04-06 16:05 ET
Medpace published news for 2022 q1
SEC form 6
2022-03-16 16:53 ET
Medpace published news for 2021 q4
SEC form 10
2022-02-15 16:06 ET
Medpace published news for 2021 q4
SEC form 10
2022-02-15 00:00 ET
Medpace published news for 2021 q4
SEC form 6
2022-02-14 16:15 ET
Medpace published news for 2021 q4
SEC form 8
2022-02-14 00:00 ET
Medpace published news for 2021 q4
SEC form 6
2021-12-29 16:40 ET
Medpace published news for 2021 q3
SEC form 10
2021-10-26 16:06 ET
Medpace published news for 2021 q3
SEC form 10
2021-10-26 00:00 ET
Medpace published news for 2021 q3
SEC form 6
2021-10-25 16:16 ET
Medpace published news for 2021 q3
SEC form 8
2021-10-25 00:00 ET
Medpace published news for 2021 q3
SEC form 6
2021-08-10 16:01 ET
Medpace published news for 2021 q2
SEC form 10
2021-07-27 16:40 ET
Medpace published news for 2021 q2
SEC form 10
2021-07-27 00:00 ET
Medpace published news for 2021 q2
SEC form 6
2021-07-26 16:30 ET
Medpace published news for 2021 q2
SEC form 6
2021-07-26 16:15 ET
Medpace published news for 2021 q2
SEC form 8
2021-07-26 00:00 ET
Medpace published news for 2021 q2
SEC form 6
2021-07-23 16:21 ET
Medpace published news for 2021 q2
SEC form 6
2021-06-11 16:15 ET
Medpace published news for 2021 q1
SEC form 6
2021-05-14 16:57 ET
Medpace published news for 2021 q1
SEC form 10
2021-04-27 16:05 ET
Medpace published news for 2021 q1
SEC form 10
2021-04-27 00:00 ET
Medpace published news for 2021 q1
SEC form 6
2021-04-26 16:16 ET
Medpace published news for 2021 q1
SEC form 8
2021-04-26 00:00 ET
Medpace published news for 2021 q1
SEC form 6
2021-03-30 17:22 ET
Medpace published news for 2020 q4
SEC form 6
2021-03-30 16:53 ET
Medpace published news for 2020 q4
SEC form 10
2021-02-16 16:11 ET
Medpace published news for 2020 q4
SEC form 6
2021-02-16 07:12 ET
Medpace published news for 2020 q4
SEC form 6
2020-10-30 16:05 ET
Medpace published news for 2020 q3
SEC form 10
2020-10-27 16:05 ET
Medpace published news for 2020 q3
SEC form 6
2020-10-26 16:15 ET
Medpace published news for 2020 q3